AMGN compared with INBX: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

INBXInhibrx Biosciences, Inc.

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

INBXInhibrx Biosciences, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

8 more · AMGN chain ›

Shared 0

No shared counterparties.

Only INBX 4

REGNRegeneron Pharmaceuticalscustomer

SNYSanoficustomer

—Scitheraunlistedcustomer

—Art Acquisition Sub

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlistedcustomer

AMGNAmgen Inc

460.67▼−1.03%· post 454.09· delayed

Mkt cap$251.6BRevenue$10.1BQ2 FY26Revenue$36.8BFY25

INBXInhibrx Biosciences, Inc.

81.31▲+12.67%· post 81.31· delayed

After hoursNov 3 '26delayed

Mkt cap$1.1BRevenue$1MQ2 FY25Revenue—

Compare

After hoursNov 3 '26delayed

AMGNAmgen Inc

INBXInhibrx Biosciences, Inc.

460.67▼−1.03%post 454.09delayed

Price

81.31▲+12.67%post 81.31delayed

$251.6B

Mkt cap

$1.1B

Q2 FY26$10.1B

Revenue

$1MQ2 FY25

FY25$36.8B

Revenue

—

AMGN460.67▼−1.03%vsINBX81.31▲+12.67%After hoursNov 3 '26delayed